Literature DB >> 22382701

Immune responses triggering colitis and colitis-associated carcinoma.

Rebecca Kesselring1, Stefan Fichtner-Feigl.   

Abstract

Inflammatory bowel diseases compromise of two forms of chronic intestinal inflammatory disorders: Crohn's disease and ulcerative colitis. Both forms of inflammatory bowel disease result from inappropriate inflammatory responses to the intestinal microbiota, but have different underlying immune responses. The connection between inflammation and cancer has long been established and longstanding inflammatory bowel diseases are an important risk factor for developing colorectal cancer. Colitis-associated colorectal cancer pathogenesis is highly influenced by specific inflammatory processes during inflammatory bowel disease. This article reviews the immunological responses affecting Crohn's disease and ulcerative colitis as well as the linkage of inflammatory bowel disease to the development of colitis-associated cancer. Finally, we discuss the prospects of using new research efforts to devise new immunotherapeutic approaches.

Entities:  

Mesh:

Year:  2012        PMID: 22382701     DOI: 10.1007/s00423-012-0927-7

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  52 in total

Review 1.  Innate lymphoid cells: emerging insights in development, lineage relationships, and function.

Authors:  Hergen Spits; Tom Cupedo
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

Review 2.  Natural killer T cells in mucosal homeostasis.

Authors:  Arthur Kaser; Edward E S Nieuwenhuis; Warren Strober; Lloyd Mayer; Ivan Fuss; Sean Colgan; Richard S Blumberg
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

Review 3.  Genetics and pathogenesis of inflammatory bowel disease.

Authors:  Bernard Khor; Agnès Gardet; Ramnik J Xavier
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

Review 4.  The machinery of Nod-like receptors: refining the paths to immunity and cell death.

Authors:  Maya Saleh
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

5.  Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice.

Authors:  Dominik Jauch; Maria Martin; Gabriela Schiechl; Rebecca Kesselring; Hans Jürgen Schlitt; Edward K Geissler; Stefan Fichtner-Feigl
Journal:  Gut       Date:  2011-09-23       Impact factor: 23.059

Review 6.  Infection, immunoregulation, and cancer.

Authors:  Graham A W Rook; Angus Dalgleish
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

Review 7.  Insights into IBD Pathogenesis.

Authors:  David Q Shih; Stephan R Targan
Journal:  Curr Gastroenterol Rep       Date:  2009-12

8.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

Review 9.  Regulatory T cells in inflammatory bowel disease.

Authors:  Elisa K Boden; Scott B Snapper
Journal:  Curr Opin Gastroenterol       Date:  2008-11       Impact factor: 3.287

Review 10.  Inflammation and colorectal cancer.

Authors:  Sarah Kraus; Nadir Arber
Journal:  Curr Opin Pharmacol       Date:  2009-07-07       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.